Environmental Factors and Colorectal Tumor Risk in Individuals with Hereditary Nonpolyposis Colorectal Cancer
Overview
Authors
Affiliations
Background & Aims: Individuals with hereditary nonpolyposis colorectal cancer (HNPCC) are at increased risk for colorectal cancer. Environmental factors might play a role in HNPCC-associated carcinogenesis. The aim of this study was to gain insight into the effects of environmental factors on colorectal tumor risk in individuals with HNPCC.
Methods: We examined associations between dietary factors, cigarette smoking, and HNPCC-associated colorectal tumors in a Dutch case-control study (145 cases, 103 tumor-free controls; all study participants were known or suspected carriers of a germline mutation in one of the DNA mismatch repair genes). We also assessed associations between the various environmental factors and occurrence of adenomatous polyposis coli (APC) mutations in HNPCC-associated polyps in a subset of the study population.
Results: Fruit consumption was inversely associated with ever developing HNPCC-associated colorectal tumors (odds ratio [95% confidence interval] for highest vs lowest tertile, 0.4 [0.2-0.9]; P(trend) = .03); a borderline significant inverse association was observed for dietary fiber intake (0.5 [0.2-1.0]; P(trend) = .06). Cigarette smoking seemed to increase the risk of HNPCC-associated colorectal tumors. Truncating APC mutations were detected in 30 (37.5%) of the 80 available HNPCC-associated polyps; frameshift mutations were most common (73.3%). None of the evaluated environmental factors was distinctively associated with a specific APC status of the polyps.
Conclusions: Our data suggest that fruit consumption and dietary fiber intake might decrease the risk of colorectal tumors in individuals with HNPCC, whereas cigarette smoking might increase the risk of HNPCC-associated colorectal tumors. The observed associations support the hypothesis that HNPCC-associated outcomes might be modified by environmental factors.
The Influence of Diet and Obesity in Lynch Syndrome: What Do We Know So Far.
Rodrigues C, Irving S, Alves P, Dinis-Ribeiro M, Brandao C, Correia M Nutrients. 2025; 16(24.
PMID: 39770972 PMC: 11677193. DOI: 10.3390/nu16244352.
Barra F, Perrone U, Ferrero S, Bogliolo S, Ottonello S, Gustavino C Ann Med. 2024; 56(1):2370568.
PMID: 38920120 PMC: 11210413. DOI: 10.1080/07853890.2024.2370568.
Narayana S, Mushtaq U, Shaman Ameen B, Nie C, Nechi D, Mazhar I Cureus. 2023; 15(7):e41939.
PMID: 37588311 PMC: 10425701. DOI: 10.7759/cureus.41939.
Lynch syndrome: from detection to treatment.
Williams M, Hadjinicolaou A, Norton B, Kader R, Lovat L Front Oncol. 2023; 13:1166238.
PMID: 37197422 PMC: 10183578. DOI: 10.3389/fonc.2023.1166238.
Loss of mismatch repair promotes a direct selective advantage in human stem cells.
Madden-Hennessey K, Gupta D, Radecki A, Guild C, Rath A, Heinen C Stem Cell Reports. 2022; 17(12):2661-2673.
PMID: 36368329 PMC: 9768573. DOI: 10.1016/j.stemcr.2022.10.009.